PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34151031-1	2021	Anisomycin is used as a chemical compound that possesses c-Jun N-terminal kinase (JNK)-activating effects.	Anisomycin	0-10	mitogen-activated protein kinase 8	Homo sapiens	57-80	
34151031-1	2021	Anisomycin is used as a chemical compound that possesses c-Jun N-terminal kinase (JNK)-activating effects.	Anisomycin	0-10	mitogen-activated protein kinase 8	Homo sapiens	82-85	
34151031-3	2021	In addition to its JNK-activating effects, anisomycin has been reported to affect gene expression in osteosarcoma, leukemia, hepatocellular carcinoma, ovarian cancer and other cancers.	Anisomycin	43-53	mitogen-activated protein kinase 8	Homo sapiens	19-22